Cisplatin/carboplatin + etoposide + vinorelbine in advanced non-small-cell lung cancer: A multicentre randomised trial

British Journal of Cancer

Volumn 74, Issue 11, 1996, Pages 1805-1811

  Comella, P ^a   Frasci, G ^a   De Cataldis, G ^b   Panza, N ^c   Cioffi, R ^d   Curcio, C ^e   Belli, M ^f   Bianco, A ^g   Ianniello, G ^h   Maiorino, L ⁱ   Della Vittoria, M ^g   Perchard, J ^a   Comella, G ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b Daprocida Hospital   (Italy)

^c CARDARELLI HOSPITAL   (Italy)

^d General Hospital   (Italy)

^e Ascalesi Hospital   (Italy)

^f General Hospital   (Italy)

^g SECOND UNIVERSITY OF NAPLES   (Italy)

^h General Hospital   (Italy)

ⁱ San Gennaro Hospital   (Italy)

Author keywords

Carboplatin; Cisplatin; Etoposide; Non small cell lung cancer; Phase III trial; Vinorelbine

Indexed keywords

CARBOPLATIN; CISPLATIN; ETOPOSIDE; NAVELBINE;

ADULT; AGED; ANEMIA; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG FATALITY; DRUG TOXICITY; FEMALE; HEART FAILURE; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; NEPHROTOXICITY; NEUROTOXICITY; NEUTROPENIA; OTOTOXICITY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROBABILITY; RANDOMIZED CONTROLLED TRIAL; SEPSIS; THROMBOCYTOPENIA; TREATMENT OUTCOME; VOMITING;

EID: 10544250649     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.634     Document Type: Article

References (32)

1. ARDIZZONI A, ADDAMO GF, BALDINI E, BORGHINI V, PORTALONE L, DE MARINIS F, LIONETTO R, CONTE PF, BRUZZI P, PENNUCCI MC, VENTURINI M, RINALDI M, ROSSO R AND SALVATI F. (1995). Mitomicyn + ifosfamide + cisplatin (MIP) vs MIP + interferon (MIP + IFN) vs cisplatin + carboplatin (PC): a phase II randomised trial in the treatment of advanced NSCLC. Br. J. Cancer, 71, 115-119.
2. BONOMI PD, FINKELSTEIN DM, RUCKDESCHEL JC, BLUM RH, GREEN MD, MASON B, HAHN R, TORMEY DC, HARRIS J, COMIS R AND GLICK J. (1989). Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer. A study of the Eastern Cooperative Oncology Group. J. Clin. Oncol., 7, 1602-1613.
3. BORING CC, SQUIRES TS AND TONG T. (1992). Cancer statistics. Cancer J. Clin., 42, 19-38.
4. BUNN PA Jr. (1989). The expanding role of cisplatin in the treatment of non-small-cell lung cancer. Semin. Oncol., 16 (Suppl 6), 1-12.
5. CASAGRANDE JT, PIKE MC AND SMITH PG. (1978). An improved approximate formula for calculating sample sizes, for comparing two binomial distributions. Biometrics, 34, 483-486.
6. COMELLA P, CASARETTI R, DAPONTE A, CANNADA BARTOLI G, PARZIALE AP, PALMIERI G AND COMELLA G. (1994). Combination of vinorelbine, cisplatin, and etoposide in advanced non-small-cell lung cancer: a pilot study. J. Chemother., 6, 67-71.
7. COX DR. (1972). Regression models and life tables. J. R. Stat. Soc., 34, 187-220.
8. CRINO' L, TONATO M, DARWISH S, MEACCI ML, CORONA E, DI COSTANZO F, BUZZI F, FORNARI G, SANTI E, BALLATORI E, SANTUCCI C AND DAVIS S. (1990). A randomized trial of three cisplatin-containing regimens in advanced non-small-cell lung cancer: a study of the Umbria Group. Cancer Chemother. Pharmacol., 26, 52-56.
9. CRINO' L, CLERICI M, FIGOLI F, CARLINI P, CECI G, CORTESI E, CARPI A, SANTINI A, DI COSTANZO F, BONI C, MEACCI M, CORGNA E, DARWISH S, SCARCELLA L, SANTUCCI A, BALLATORI E AND TONATO M. (1995). Chemotherapy of advanced non-small-cell lung cancer: a comparison of three active regimens. A randomized trial of the Italian Oncology Group for Clinical Research (G.O.I.R.C.). Ann. Oncol., 6, 347-353.
10. CRINO' L, SCAGLIOTTI G, MARANGOLO M, FIGOLI F, CLERICI M, DE MARINIS F, SALVATI F, CRUCIANI G, DOGLIOTTI L, COCCONI G, PACCAGNELLA A, ADAMO V, INCORONATO P, SCARCELLA L, MOSCONI AM AND TONATO M. (1995). Cisplatin-gemcitabine combination in non-small cell lung cancer. A phase II study. Proc. Am. Soc. Clin. Oncol., 14, 352.
11. CROS S, WRIGHT M, MORIMOTO M, LATASTE H, COUZINIER JP AND KRIKORIAN A. (1989). Experimental antitumor activity of navelbine. Semin. Oncol., 16 (suppl. 4), 15-20.
12. DEPIERRE A, LEMARIE E, DABOUIS G, GARNIER G, JACOULET P AND DALPHIN JC. (1989). Efficacy of navelbine in non-small-cell lung cancer. Semin. Oncol., 16 (suppl. 4), 26-29.
13. DONNADIEU N, PAESMANS M AND SCULIER JP. (1991). Chemotherapy of non-small cell lung cancer according to disease extent: a meta-analysis of the literature. Lung Cancer, 7, 243-252.
14. FAULDS D. (1992). Current options in the treatment of non-small cell lung cancer. Drugs, 44 (suppl. 4), 46-59.
15. FISHER RA AND YATES F. (1963). Statistical Tables for Biological, Agricultural and Medical Research. Oliver & Boyd: Edinburgh.
16. FISHER RA. (1950). The significance of deviations from expectations in a Poisson series. Biometrics, 15, 17-24.
17. GRILLI R, OXMAN AD AND JULIAN JA. (1993). Chemotherapy for advanced non-small-cell lung cancer: how much benefit is enough? J. Clin. Oncol., 11, 1866-1872.
18. HAINSWORTH J, JOHNSON D AND HANDE K. (1989). Chemotherapy of advanced non-small cell lung cancer: a randomized trial of three cisplatin-based chemotherapy regimens. Am. J. Clin. Oncol., (CCT) 12, 345-349.
19. IHDE DC. (1992). Chemotherapy of lung cancer. N. Engl. J. Med., 327, 1434-1441.
20. KAPLAN ES AND MEIER P. (1958). Non parametric estimation for incomplete observations. J. Am. Stat. Assoc., 53, 457-480.
21. JACOULET P, DEPIERRE A, GARNIER G AND DALPHIN JC. (1991). Study of combined navelbine-cisplatin-VP16 in the treatment of non-small lung cancer. In Navelbine (Vinorelbine) Update and New Trends. Pierre Fabre Oncologie (eds) pp. 171-177. John Libbey Eurotext: Montrouge.
22. LANGER CJ, LEIGHTON J, COMIS R, O'DWYER P, McALEER C, BONJO C, ENGSTROM PF, LITWIN S AND OZOLS R. (1995). Paclitaxel and carboplatin in combination in the treatment of advanced non-small cell lung cancer: a phase II toxicity, response, and survival analysis. J. Clin. Oncol., 13, 1860-1870.
23. LE CHEVALIER T, BRISGAND D, DOUILLARD JY, PUJOL JL, ALBEROLA V, MONNIER A, RIVIERE A, LIANES P, CHOMY P, CIGOLARI S, GOTTFRIED M, RUFFIE P, PANIZO A, GASPARD MH, RAVAIOLI A, BESENVAL M, BESSON F, MARTINEZ A, BERTHAUD P AND TURSZ T. (1994). Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European Multicenter Trial incuding 612 patients. J. Clin. Oncol., 12, 360-367.
24. MANTEL N. (1966). Evaluation of survival data and two new-rank order statistics arising in its consideration. Cancer Chemother. Rep., 50, 163-170.
25. MILLER AB, HOOGSTRATEN B, STAQUET M AND WINKEN A. (1981). Reporting results on cancer treatment. Cancer, 47, 207-214.
26. SAKURAI M, ICHIKI M, OHASHI Y AND HAYASHI I. (1993). Phase II study of a combination regimen composed of cisplatin, carboplatin and etoposide (CPVP) in unresectable non-small cell lung cancer (NSCLC). Proc. Am. Soc. Clin. Oncol., 12, 343.
27. SCULIER JP, KLASTERSKY J, GINER V, BUREAU G, THIRIAUX J, DABOUIS G, EFREMIDIS A, RIES F, BERCHIER MC, SERGYSELS R, MOMMEN P AND PAESMANS M. (1994). Phase II randomized trial comparing high-dose cisplatin with moderate-dose cisplatin and carboplatin in patients with advanced non-small-cell lung cancer. J. Clin. Oncol., 12, 353-359.
28. THALL PF, SIMON R, ELLENBERG SS AND SHRAGER R. (1988). Optimal two-stage designs for clinical trials with binary response. Stat. Med., 7, 571-579.
29. TSUCHIYA S, SALTOH R, NAKANO H, MINATO K, TAKISE A, EZAWA K, FUEKI N, HOSHINO H, MAKIMOTO T, NARUSE I, NOMOTO T, TAKEI Y, ISHIHARA S, WATANABE S AND MORI M. (1993). Escalated dose carboplatin (CBDCA) with cisplatin (CDDP) + etoposide (VP16) for advanced non-small cell lung cancer (NSCLC): a phase I study. Proc. Am. Soc. Clin. Oncol., 12, 353.
30. WEICK JK, CROWLEY J, NATALE RB, HOM BL, RIVKIN S, COLTMAN CA JR, TAYLR SA AND LIVINGSTON RB (1991). A randomized trial of five cisplatin-containing treatments in patients with metastatic non-small cell lung cancer: a Southwest Oncology Group Study. J. Clin. Oncol., 7, 1157-1162.
31. WILKINSON AND LELAND. (1988). The System for Statistics. Systat: Evanston, IL.
32. ZALCBERG JR, BISHOP JF, MILLWARD MJ, ZIMET A, LAIRD J, BARTER C, SEWARD D, MCKEAGE MJ, FRIEDLANDER ML, TONER G, BERILLE J AND BLANC C. (1995). Preliminary results of the first phase II trial of docetaxel in combination with cisplatin in patients with metastatic or locally advanced non-small cell lung cancer. Proc. Am. Soc. Clin. Oncol., 14, 351.